nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Trovafloxacin—TOP2A—breast cancer	0.00402	0.156	CrCbGaD
Gemifloxacin—Moxifloxacin—TOP2A—breast cancer	0.00304	0.118	CrCbGaD
Gemifloxacin—Pefloxacin—TOP2A—breast cancer	0.00222	0.0864	CrCbGaD
Gemifloxacin—Enoxacin—TOP2A—breast cancer	0.00208	0.0809	CrCbGaD
Gemifloxacin—Sparfloxacin—TOP2A—breast cancer	0.00191	0.0744	CrCbGaD
Gemifloxacin—Ofloxacin—ABCC1—breast cancer	0.00174	0.0679	CrCbGaD
Gemifloxacin—Lomefloxacin—TOP2A—breast cancer	0.00157	0.0613	CrCbGaD
Gemifloxacin—Levofloxacin—TOP2A—breast cancer	0.00135	0.0524	CrCbGaD
Gemifloxacin—Ofloxacin—TOP2A—breast cancer	0.00135	0.0524	CrCbGaD
Gemifloxacin—Ciprofloxacin—TOP2A—breast cancer	0.0013	0.0506	CrCbGaD
Gemifloxacin—Norfloxacin—TOP2A—breast cancer	0.00109	0.0425	CrCbGaD
Gemifloxacin—Gatifloxacin—ALB—breast cancer	0.000873	0.034	CrCbGaD
Gemifloxacin—Norfloxacin—CYP1A1—breast cancer	0.000584	0.0227	CrCbGaD
Gemifloxacin—Sparfloxacin—ABCB1—breast cancer	0.000544	0.0212	CrCbGaD
Gemifloxacin—Levofloxacin—CYP3A4—breast cancer	0.00046	0.0179	CrCbGaD
Gemifloxacin—Ciprofloxacin—CYP3A4—breast cancer	0.000444	0.0173	CrCbGaD
Gemifloxacin—Levofloxacin—ABCB1—breast cancer	0.000383	0.0149	CrCbGaD
Gemifloxacin—Norfloxacin—CYP3A4—breast cancer	0.000373	0.0145	CrCbGaD
Gemifloxacin—Ciprofloxacin—ABCB1—breast cancer	0.00037	0.0144	CrCbGaD
Gemifloxacin—Pharyngitis—Epirubicin—breast cancer	0.00022	0.000226	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—breast cancer	0.00022	0.000226	CcSEcCtD
Gemifloxacin—Skin disorder—Capecitabine—breast cancer	0.00022	0.000226	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—breast cancer	0.000219	0.000225	CcSEcCtD
Gemifloxacin—Urticaria—Paclitaxel—breast cancer	0.000219	0.000225	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Capecitabine—breast cancer	0.000219	0.000225	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—breast cancer	0.000219	0.000225	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—breast cancer	0.000218	0.000224	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—breast cancer	0.000218	0.000224	CcSEcCtD
Gemifloxacin—Abdominal pain—Paclitaxel—breast cancer	0.000218	0.000224	CcSEcCtD
Gemifloxacin—Body temperature increased—Paclitaxel—breast cancer	0.000218	0.000224	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—breast cancer	0.000218	0.000224	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—breast cancer	0.000217	0.000222	CcSEcCtD
Gemifloxacin—Anorexia—Capecitabine—breast cancer	0.000216	0.000222	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—breast cancer	0.000215	0.000221	CcSEcCtD
Gemifloxacin—Vomiting—Irinotecan—breast cancer	0.000215	0.000221	CcSEcCtD
Gemifloxacin—Vomiting—Mitoxantrone—breast cancer	0.000215	0.000221	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—breast cancer	0.000214	0.00022	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—breast cancer	0.000214	0.00022	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—breast cancer	0.000214	0.00022	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—breast cancer	0.000214	0.00022	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—breast cancer	0.000214	0.000219	CcSEcCtD
Gemifloxacin—Rash—Mitoxantrone—breast cancer	0.000213	0.000219	CcSEcCtD
Gemifloxacin—Rash—Irinotecan—breast cancer	0.000213	0.000219	CcSEcCtD
Gemifloxacin—Dermatitis—Mitoxantrone—breast cancer	0.000213	0.000219	CcSEcCtD
Gemifloxacin—Dermatitis—Irinotecan—breast cancer	0.000213	0.000219	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000213	0.000219	CcSEcCtD
Gemifloxacin—Headache—Mitoxantrone—breast cancer	0.000212	0.000218	CcSEcCtD
Gemifloxacin—Headache—Irinotecan—breast cancer	0.000212	0.000218	CcSEcCtD
Gemifloxacin—Insomnia—Docetaxel—breast cancer	0.000212	0.000217	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—breast cancer	0.00021	0.000216	CcSEcCtD
Gemifloxacin—Vomiting—Gemcitabine—breast cancer	0.00021	0.000215	CcSEcCtD
Gemifloxacin—Dyspnoea—Docetaxel—breast cancer	0.000209	0.000214	CcSEcCtD
Gemifloxacin—Somnolence—Docetaxel—breast cancer	0.000208	0.000214	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—breast cancer	0.000208	0.000213	CcSEcCtD
Gemifloxacin—Rash—Gemcitabine—breast cancer	0.000208	0.000213	CcSEcCtD
Gemifloxacin—Dermatitis—Gemcitabine—breast cancer	0.000208	0.000213	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—breast cancer	0.000208	0.000213	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—breast cancer	0.000207	0.000212	CcSEcCtD
Gemifloxacin—Headache—Gemcitabine—breast cancer	0.000207	0.000212	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000206	0.000212	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—breast cancer	0.000206	0.000212	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—breast cancer	0.000206	0.000212	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—breast cancer	0.000206	0.000212	CcSEcCtD
Gemifloxacin—Dyspepsia—Docetaxel—breast cancer	0.000206	0.000211	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—breast cancer	0.000206	0.000211	CcSEcCtD
Gemifloxacin—Insomnia—Capecitabine—breast cancer	0.000205	0.00021	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—breast cancer	0.000204	0.00021	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—breast cancer	0.000204	0.00021	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—breast cancer	0.000204	0.000209	CcSEcCtD
Gemifloxacin—Decreased appetite—Docetaxel—breast cancer	0.000203	0.000209	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—breast cancer	0.000203	0.000208	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—breast cancer	0.000203	0.000208	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—breast cancer	0.000202	0.000208	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—breast cancer	0.000202	0.000208	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Dyspnoea—Capecitabine—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Fatigue—Docetaxel—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Gemifloxacin—Nausea—Irinotecan—breast cancer	0.000201	0.000206	CcSEcCtD
Gemifloxacin—Nausea—Mitoxantrone—breast cancer	0.000201	0.000206	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—breast cancer	0.000201	0.000206	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—breast cancer	0.0002	0.000205	CcSEcCtD
Gemifloxacin—Constipation—Docetaxel—breast cancer	0.0002	0.000205	CcSEcCtD
Gemifloxacin—Pain—Docetaxel—breast cancer	0.0002	0.000205	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—breast cancer	0.0002	0.000205	CcSEcCtD
Gemifloxacin—Dyspepsia—Capecitabine—breast cancer	0.000199	0.000205	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—breast cancer	0.000198	0.000203	CcSEcCtD
Gemifloxacin—Asthenia—Paclitaxel—breast cancer	0.000198	0.000203	CcSEcCtD
Gemifloxacin—Decreased appetite—Capecitabine—breast cancer	0.000197	0.000202	CcSEcCtD
Gemifloxacin—Nausea—Gemcitabine—breast cancer	0.000196	0.000201	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000196	0.000201	CcSEcCtD
Gemifloxacin—Fatigue—Capecitabine—breast cancer	0.000195	0.0002	CcSEcCtD
Gemifloxacin—Pruritus—Paclitaxel—breast cancer	0.000195	0.0002	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—breast cancer	0.000195	0.0002	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—breast cancer	0.000194	0.000199	CcSEcCtD
Gemifloxacin—Constipation—Capecitabine—breast cancer	0.000194	0.000199	CcSEcCtD
Gemifloxacin—Pain—Capecitabine—breast cancer	0.000194	0.000199	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—breast cancer	0.000193	0.000198	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—breast cancer	0.000192	0.000197	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Docetaxel—breast cancer	0.000191	0.000196	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—breast cancer	0.000191	0.000196	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—breast cancer	0.000191	0.000196	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—breast cancer	0.000191	0.000196	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—breast cancer	0.000191	0.000196	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—breast cancer	0.00019	0.000195	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—breast cancer	0.000189	0.000194	CcSEcCtD
Gemifloxacin—Diarrhoea—Paclitaxel—breast cancer	0.000189	0.000194	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—breast cancer	0.000188	0.000193	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—breast cancer	0.000187	0.000192	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—breast cancer	0.000187	0.000191	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—breast cancer	0.000186	0.000191	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—breast cancer	0.000186	0.000191	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—breast cancer	0.000186	0.000191	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Capecitabine—breast cancer	0.000185	0.00019	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—breast cancer	0.000185	0.00019	CcSEcCtD
Gemifloxacin—Abdominal pain—Docetaxel—breast cancer	0.000185	0.00019	CcSEcCtD
Gemifloxacin—Body temperature increased—Docetaxel—breast cancer	0.000185	0.00019	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—breast cancer	0.000185	0.00019	CcSEcCtD
Gemifloxacin—Dizziness—Paclitaxel—breast cancer	0.000183	0.000187	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—breast cancer	0.00018	0.000185	CcSEcCtD
Gemifloxacin—Urticaria—Capecitabine—breast cancer	0.00018	0.000185	CcSEcCtD
Gemifloxacin—Abdominal pain—Capecitabine—breast cancer	0.000179	0.000184	CcSEcCtD
Gemifloxacin—Body temperature increased—Capecitabine—breast cancer	0.000179	0.000184	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—breast cancer	0.000179	0.000183	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—breast cancer	0.000176	0.000181	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—breast cancer	0.000176	0.000181	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—breast cancer	0.000176	0.000181	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—breast cancer	0.000176	0.00018	CcSEcCtD
Gemifloxacin—Vomiting—Paclitaxel—breast cancer	0.000176	0.00018	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—breast cancer	0.000175	0.00018	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000175	0.000179	CcSEcCtD
Gemifloxacin—Rash—Paclitaxel—breast cancer	0.000174	0.000179	CcSEcCtD
Gemifloxacin—Dermatitis—Paclitaxel—breast cancer	0.000174	0.000178	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—breast cancer	0.000174	0.000178	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—breast cancer	0.000174	0.000178	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—breast cancer	0.000173	0.000178	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—breast cancer	0.000173	0.000178	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—breast cancer	0.000173	0.000178	CcSEcCtD
Gemifloxacin—Headache—Paclitaxel—breast cancer	0.000173	0.000178	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—breast cancer	0.000172	0.000177	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—breast cancer	0.000171	0.000175	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—breast cancer	0.00017	0.000174	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—breast cancer	0.000169	0.000173	CcSEcCtD
Gemifloxacin—Asthenia—Docetaxel—breast cancer	0.000168	0.000172	CcSEcCtD
Gemifloxacin—Pruritus—Docetaxel—breast cancer	0.000166	0.00017	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—breast cancer	0.000165	0.00017	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—breast cancer	0.000165	0.00017	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—breast cancer	0.000165	0.000169	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—breast cancer	0.000165	0.000169	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—breast cancer	0.000165	0.000169	CcSEcCtD
Gemifloxacin—Nausea—Paclitaxel—breast cancer	0.000164	0.000168	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—breast cancer	0.000164	0.000168	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000164	0.000168	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—breast cancer	0.000163	0.000167	CcSEcCtD
Gemifloxacin—Asthenia—Capecitabine—breast cancer	0.000163	0.000167	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—breast cancer	0.000161	0.000165	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—breast cancer	0.000161	0.000165	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—breast cancer	0.000161	0.000165	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—breast cancer	0.00016	0.000165	CcSEcCtD
Gemifloxacin—Pruritus—Capecitabine—breast cancer	0.00016	0.000165	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—breast cancer	0.00016	0.000164	CcSEcCtD
Gemifloxacin—Diarrhoea—Docetaxel—breast cancer	0.00016	0.000164	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—breast cancer	0.000158	0.000162	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—breast cancer	0.000158	0.000162	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—breast cancer	0.000158	0.000162	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—breast cancer	0.000157	0.000161	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—breast cancer	0.000155	0.000159	CcSEcCtD
Gemifloxacin—Diarrhoea—Capecitabine—breast cancer	0.000155	0.000159	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—breast cancer	0.000155	0.000159	CcSEcCtD
Gemifloxacin—Dizziness—Docetaxel—breast cancer	0.000155	0.000159	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—breast cancer	0.000155	0.000159	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—breast cancer	0.000154	0.000158	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000154	0.000158	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—breast cancer	0.000153	0.000157	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—breast cancer	0.000153	0.000157	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—breast cancer	0.000153	0.000157	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—breast cancer	0.000152	0.000156	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—breast cancer	0.000152	0.000156	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000151	0.000155	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—breast cancer	0.00015	0.000154	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—breast cancer	0.00015	0.000154	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—breast cancer	0.00015	0.000154	CcSEcCtD
Gemifloxacin—Dizziness—Capecitabine—breast cancer	0.00015	0.000154	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—breast cancer	0.000149	0.000153	CcSEcCtD
Gemifloxacin—Vomiting—Docetaxel—breast cancer	0.000149	0.000153	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—breast cancer	0.000148	0.000152	CcSEcCtD
Gemifloxacin—Rash—Docetaxel—breast cancer	0.000148	0.000151	CcSEcCtD
Gemifloxacin—Dermatitis—Docetaxel—breast cancer	0.000147	0.000151	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—breast cancer	0.000147	0.00015	CcSEcCtD
Gemifloxacin—Headache—Docetaxel—breast cancer	0.000147	0.00015	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—breast cancer	0.000146	0.00015	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—breast cancer	0.000146	0.00015	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000146	0.000149	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—breast cancer	0.000145	0.000149	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—breast cancer	0.000144	0.000148	CcSEcCtD
Gemifloxacin—Vomiting—Capecitabine—breast cancer	0.000144	0.000148	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000144	0.000148	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—breast cancer	0.000144	0.000147	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—breast cancer	0.000143	0.000147	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—breast cancer	0.000143	0.000147	CcSEcCtD
Gemifloxacin—Rash—Capecitabine—breast cancer	0.000143	0.000147	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—breast cancer	0.000143	0.000147	CcSEcCtD
Gemifloxacin—Dermatitis—Capecitabine—breast cancer	0.000143	0.000146	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—breast cancer	0.000143	0.000146	CcSEcCtD
Gemifloxacin—Headache—Capecitabine—breast cancer	0.000142	0.000146	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—breast cancer	0.000142	0.000146	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—breast cancer	0.000141	0.000145	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—breast cancer	0.000141	0.000144	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—breast cancer	0.00014	0.000144	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—breast cancer	0.000139	0.000143	CcSEcCtD
Gemifloxacin—Nausea—Docetaxel—breast cancer	0.000139	0.000143	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—breast cancer	0.000139	0.000143	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—breast cancer	0.000138	0.000142	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—breast cancer	0.000137	0.000141	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000136	0.00014	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—breast cancer	0.000136	0.00014	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—breast cancer	0.000135	0.000139	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—breast cancer	0.000135	0.000139	CcSEcCtD
Gemifloxacin—Nausea—Capecitabine—breast cancer	0.000135	0.000138	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—breast cancer	0.000134	0.000138	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—breast cancer	0.000133	0.000137	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—breast cancer	0.000133	0.000137	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000133	0.000137	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—breast cancer	0.000132	0.000136	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—breast cancer	0.00013	0.000134	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—breast cancer	0.00013	0.000133	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—breast cancer	0.000129	0.000132	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—breast cancer	0.000129	0.000132	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—breast cancer	0.000127	0.00013	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000126	0.000129	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—breast cancer	0.000126	0.000129	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—breast cancer	0.000125	0.000129	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—breast cancer	0.000121	0.000124	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—breast cancer	0.000119	0.000123	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—breast cancer	0.000119	0.000122	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—breast cancer	0.000116	0.000119	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—breast cancer	0.000115	0.000118	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—breast cancer	0.000115	0.000118	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—breast cancer	0.000115	0.000118	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—breast cancer	0.000113	0.000116	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—breast cancer	0.000112	0.000115	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—breast cancer	0.000112	0.000114	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—breast cancer	0.000108	0.000111	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—breast cancer	0.000107	0.00011	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—breast cancer	0.000106	0.000109	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—breast cancer	0.000106	0.000109	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—breast cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—breast cancer	0.000105	0.000108	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—breast cancer	0.000104	0.000107	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—breast cancer	0.000103	0.000106	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—breast cancer	0.0001	0.000103	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—breast cancer	0.0001	0.000103	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—breast cancer	9.99e-05	0.000103	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—breast cancer	9.95e-05	0.000102	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—breast cancer	9.94e-05	0.000102	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—breast cancer	9.89e-05	0.000101	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—breast cancer	9.66e-05	9.91e-05	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—breast cancer	9.38e-05	9.62e-05	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—breast cancer	9.29e-05	9.53e-05	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—breast cancer	9.21e-05	9.45e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—breast cancer	9.2e-05	9.44e-05	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—breast cancer	9.15e-05	9.39e-05	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—breast cancer	8.67e-05	8.9e-05	CcSEcCtD
